CFM
LNAI

Compass Financial Management’s Lunai Bioworks LNAI Stock Holding History

Compass Financial Management’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409 Buy
+125
New +$344 ﹤0.01% 1429

Other funds holding LNAI

GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Compass Financial Management's LNAI Position: Q2 2026 in Review

Compass Financial Management opened a new position in Lunai Bioworks (LNAI) in Q2 2026: 125 shares worth $409. The stake represents ﹤0.01% of the portfolio and ranks #1429 among its holdings.

15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

  • Compass Financial Management held 125 shares of Lunai Bioworks worth $409 as of Q2 2026.
  • Lunai Bioworks was a new Compass Financial Management position in Q2 2026.
  • Lunai Bioworks made up ﹤0.01% of Compass Financial Management's portfolio in Q2 2026, its #1429 holding.
  • 15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on Compass Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.